Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

Neoadjuvant chemotherapy (NACT) was developed with the aims of shrinking tumors or stopping cancer cells from spreading before surgery. Unfortunately, not all breast cancer patients will benefit from NACT, and thus, patients must weigh the risks and benefits of treatment prior to the initiation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Liqin, Jia, Gang, Lu, Lingeng, Ma, Wenxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320700/
https://www.ncbi.nlm.nih.gov/pubmed/35877249
http://dx.doi.org/10.3390/curroncol29070389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320700/
https://www.ncbi.nlm.nih.gov/pubmed/35877249
http://dx.doi.org/10.3390/curroncol29070389

Ejemplares similares